ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

 Click here to read this article as a CME activity

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thomas Walther
Ardawan Rastan
Volkmar Falk
Friedrich W. Mohr
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lehmann, S.
Right arrow Articles by Mohr, F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lehmann, S.
Right arrow Articles by Mohr, F. W.
Related Collections
Right arrow Valve disease

Ann Thorac Surg 2007;84:467-472
© 2007 The Society of Thoracic Surgeons

Original Articles: Cardiovascular

Stentless Versus Conventional Xenograft Aortic Valve Replacement: Midterm Results of a Prospectively Randomized Trial

Sven Lehmann, MD, Thomas Walther, MD, PhD*, Jörg Kempfert, MD, Sergey Leontjev, MD, Ardawan Rastan, MD, Volkmar Falk, MD, PhD, Friedrich W. Mohr, MD, PhD

Department of Cardiac Surgery, Heartcenter, University of Leipzig, Leipzig, Germany

Accepted for publication February 6, 2007.

* Address correspondence to Dr Walther, Universität Leipzig, Herzzentrum, Klinik für Herzchirurgie, Strümpellstr 39, Leipzig 04289, Germany (Email: walt{at}medizin.uni-leipzig.de).

Background: The purpose of this study was to analyze the 5- to 8-year clinical results after prospectively randomized stentless versus conventional aortic valve replacement.

Methods: Two hundred twenty-three patients received stentless (Freestyle or Toronto, n = 127) or conventional stented (CE porcine, n = 96) xenograft aortic valve replacement between March 1996 and March 1999 using a prospectively randomized protocol and were discharged from the hospital. Patient age at operation was 71.8 ± 6.7 years stentless and 74.9 ± 4 years stented (p < 0.05). There were no significant differences regarding preoperative morphologic and hemodynamic variables. Aortic annulus diameter indices were comparable at 13.5 mm stentless and 13.6 mm stented. Follow-up after 6.9 ± 0.8 years is complete for 95.6% of the patients at a total of 1,533 patient-years. Analysis of variance, unpaired t test, univariate ({chi}2), and survival analysis (log rank) were performed.

Results: Eight-year survival was 78.1% ± 3.8% stentless versus 66% ± 4.9% stented (p = 0.04); mean survival was 97 months stentless versus 88 months stented. At most recent follow-up, New York Heart Association functional class was 1.6 ± 0.6 stentless versus 1.5 ± 0.7 stented (p = not significant); ejection fraction was 61% ± 11% versus 61% ± 8% (p = not significant); transvalvular maximum flow velocity was 23 ± 9 mm Hg versus 37 ± 15 mm Hg (p < 0.01). Thrombembolic events occurred in 2 of 7 patients, including 2 of 6 patients suffering major stroke (p = not significant). Most (93%) of the patients were satisfied with the postoperative course, having a significantly improved quality of life.

Conclusions: Midterm results after xenograft aortic valve replacement are satisfactory. Overall survival is significantly better after stentless aortic valve replacement in this series. However, there was no cause and effect relationship between lower transvalvular pressure gradient. Fewer thrombembolic events and better survival rates were proven.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The Society of Thoracic Surgeons.